Repligen Corporation (NASDAQ:RGEN) will hold its 3Q20 earnings conference call with the financial community on 5th November 2020 at 8:30 AM Eastern Time.
The conference call will be webcast live on Internet at www.repligen.com
Earnings Expectation
Repligen Corporation is reporting third quarter financial results on Thursday 5th November 2020, before market open.
According to analysts surveyed by Thomson Reuters, RGEN is expected to report 3Q20 income of $ 0.28 per share from revenue of $ 86.45 million.
For the full year, analysts anticipate top line of $ 337.53 million, while looking forward to income of $ 1.28 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 332.00 million ~ $ 340.00 million, where as bottomline are predicted in a range of $ 1.24 ~ $ 1.29 per share
Click Here For More Historical Outlooks Of Repligen Corporation
Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally. It offers Protein A ligands to life sciences companies, which are the binding components of Protein A affinity resins; and growth factor products used to supplement cell culture media. The company also provides chromatography products comprising OPUS pre-packed chromatography columns, which are used in the purification of antibodies, recombinant proteins, and vaccines; and OPUS PD smaller-scale columns that are used in the high throughput process development screening, viral validation studies, and scale down validation of chromatography processes.
